American Bio Medica Corporation
ABMCOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$4810
P/E Ratio—
52W High$0.0002
52W Low$0.0001
American Bio Medica Corporation (ABMC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABMC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.91M | $2.22M | $4.15M | $3.65M | $3.87M |
| Cost of Revenue | $1.11M | $1.67M | $2.91M | $2.47M | $2.58M |
| Gross Profit | ($0.19M) | $0.55M | $1.24M | $1.18M | $1.29M |
| Gross Margin %(computed) | -21.14% | 24.71% | 29.85% | 32.39% | 33.26% |
| Operating Expenses | |||||
| R&D Expenses | $0.09M | $0.09M | $0.09M | $0.08M | $0.09M |
| G&A Expenses | $0.92M | $1.34M | $1.28M | $1.24M | $1.41M |
| Total Operating Expenses | $1.05M | $1.73M | $1.86M | $1.78M | $2.05M |
| Operating Income | ($1.24M) | ($1.18M) | ($0.62M) | ($0.59M) | ($0.76M) |
| Operating Margin %(computed) | -136.04% | -53.16% | -14.97% | -16.22% | -19.68% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.19M | $0.19M | $0.17M | $0.27M | $0.28M |
| Income Before Tax | ($1.41M) | ($0.46M) | ($0.79M) | ($0.69M) | ($1.03M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.01M) | $0.00M |
| Net Income | ($1.41M) | ($0.46M) | ($0.80M) | ($0.68M) | ($1.03M) |
| Net Margin %(computed) | -154.44% | -20.87% | -19.19% | -18.63% | -26.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.01 | $-0.02 | $-0.02 | $-0.03 |
| Wtd Avg Shares | 48.02M | 42.76M | 35.56M | 32.53M | 30.12M |
| EBITDA | ($1.16M) | ($0.20M) | ($0.54M) | ($0.34M) | ($0.66M) |
| EBITDA Margin %(computed) | -127.38% | -8.97% | -13.02% | -9.30% | -17.07% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more American Bio Medica Corporation data
About American Bio Medica Corporation (ABMC) Income Statement
American Bio Medica Corporation (ABMC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ABMC reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -21.14%), and net income of ($0.00B) — a net profit margin of -154.44%.
Frequently asked questions
ABMC · 4 questionsAmerican Bio Medica Corporation (ABMC) reported revenue of $0.00B for 2022, down 58.8% year-over-year.
ABMC revenueABMC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09